Capital International Investors Files Amended Schedule 13G for Arxis, Inc.
Capital International Investors submitted an amended Schedule 13G filing with the SEC regarding its beneficial ownership stake in Arxis, Inc.
Filings · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Capital International Investors submitted an amended Schedule 13G filing with the SEC regarding its beneficial ownership stake in Arxis, Inc.
Morgan Stanley has maintained an 'Overweight' rating on Arxis, Inc. and increased its price target from $62 to $66.
RBC Capital Markets has increased its price target for Arxis, Inc. from $60 to $64 while maintaining an "Outperform" rating.
Arxis, Inc. reported third-quarter 2026 revenue of $564.0 million and adjusted earnings per share of $0.37, both exceeding analyst expectations.